Omnia challenges PainTEQ Intellectual Property
In other words, the PTAB decided it would allow Omnia Medical's Petition for inter parties review of PainTEQ patent "11,020,129 B2 Drill-less Method of Fusing a Sacroiliac Joint" to proceed, finding that there is reasonable likelihood that challenged claims 1, 2, 9, and 10 in the PaintTEQ patent, U.S. 11,020,129, (the '129 patent) are invalid in view of the grounds presented in Omnia Medical's petition.
- In other words, the PTAB decided it would allow Omnia Medical's Petition for inter parties review of PainTEQ patent "11,020,129 B2 Drill-less Method of Fusing a Sacroiliac Joint" to proceed, finding that there is reasonable likelihood that challenged claims 1, 2, 9, and 10 in the PaintTEQ patent, U.S. 11,020,129, (the '129 patent) are invalid in view of the grounds presented in Omnia Medical's petition.
- "We are pleased with the PTAB's decision and look forward to the final resolution of this petition.
- As is evidenced by our existing and expanding patent portfolio and resulting consolidated Federal Courts cases with PainTEQ, we take Intellectual Property rights very seriously."
- said Troy Schifano, CEO of Omnia Medical.